Giuseppe N. Conti
Catania, 95123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and Safety of Cabotegravir-Rilpivirine in PLWH: A Real-World Study.
Journal: Viruses
Published: October 01, 2025
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation.
Journal: Pathogens (Basel, Switzerland)
Published: May 20, 2025
Postoperative Biochemical Outcomes in Metabolic Bariatric Surgery: Results from a High-Adherence Cohort.
Journal: Journal of personalized medicine
Published: September 28, 2024
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort.
Journal: Biomedicines
Published: August 29, 2024
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96‑week retrospective study.
Journal: Biomedical reports
Published: August 01, 2024
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma.
Journal: Journal of translational medicine
Published: June 05, 2024
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity.
Journal: Frontiers in pharmacology
Published: March 21, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026